# Mirabegron

NDC: 70710-1159
Generic name: Mirabegron
Labeler / Manufacturer: Zydus Pharmaceuticals (USA) Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20240123

FDA application: ANDA209488

## Active ingredients

- MIRABEGRON: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1159"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1159
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e40eb74-3b2a-47f7-bf31-fe27484f9bd2